Global Anticoagulants Market Industry Analysis, Size, Share, Growth, Trends & Forecast 2018-2026 - ResearchAndMarkets.com

DUBLIN--()--The "Anticoagulants Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026" report has been added to ResearchAndMarkets.com's offering

Anticoagulants prevent clot formation or enlargement of existing clots in the arteries or veins. Heparins, including unfractionated heparin (UFH) and low molecular weight heparin (LMWH); vitamin K antagonists, DTIs, and factor Xa inhibitors, are the various anticoagulants available in the market. These are used for indications such as heart attack, stroke, deep venous thrombosis (DVT), pulmonary embolism (PE), surgery, angina, dialysis, atrial fibrillation (AF), thrombocytopenia, and myocardial infarction.

This report analyzes the current and future prospects of the global anticoagulants market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary researches. Detailed qualitative analysis of factors responsible for driving and restraining the market and opportunities has been provided in the overview section. Market revenue in terms of US$ Mn for the period between 2016 and 2026 along with the compound annual growth rate (CAGR %) from 2018 to 2026 are provided for all the segments, considering 2017 as the base year. Market related factors such as technological developments, product innovation, and expansion of infrastructural facilities by major & small major products, and historical year-on-year growth have been taken into consideration while estimating the market size. Growth rates for each segments of the global anticoagulants market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, product development life cycle, and regulatory requirements. These factors would help the players to take strategic decisions in order to strengthen their positions and expand their share in the global market.

Key Topics Covered:

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Anticoagulants Market

4. Market Overview

4.1. Introduction

4.1.1. Route of Administration Definition

4.1.2. Industry Evolution/Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.3.4. Market Trends

4.4. Global Anticoagulants market analysis and Forecast, 2016-2026

4.5. Porter's Five Force Analysis

5. Market Outlook

5.1. Key Mergers & Acquisitions

6. Global Anticoagulants Market Analysis and Forecast, by Route of Administration

6.1. Introduction & Definition

6.2. Key Findings/Developments

6.3. Market Value Forecast, by Route of Administration, 2016-2026

6.3.1. Oral

6.3.2. Injectable

6.4. Market Attractiveness, by Route of Administration

7. Global Anticoagulants Market Analysis and Forecast, by Drug Class

7.1. Introduction & Definition

7.2. Key Findings/Developments

7.3. Market Value Forecast, by Drug Class, 2016-2026

7.3.1. Factor XA Inhibitors (NOAC/DOAC)

7.3.2. Heparins

7.3.3. Direct Thrombin Inhibitors

7.3.4. Vitamin K Antagonists

7.4. Market Attractiveness, by Drug Class

8. Global Anticoagulants Market Analysis and Forecast, by Indication

8.1. Introduction & Definition

8.2. Key Findings/Developments

8.3. Market Value Forecast, by Distribution Channel, 2016-2026

8.3.1. Deep Vein Thrombosis

8.3.2. Pulmonary Embolism

8.3.3. Atrial Fibrillation & Heart Attack

8.3.4. Others

8.4. Market Attractiveness, by Distribution Channel

9. Global Anticoagulants Market Analysis and Forecast, by Distribution Channel

9.1. Introduction & Definition

9.2. Key Findings/Developments

9.3. Market Value Forecast, by Distribution Channel, 2016-2026

9.3.1. Hospital Pharmacies

9.3.2. Retail Pharmacies

9.3.3. Online Pharmacies

9.4. Market Attractiveness, by Distribution Channel

10. Global Anticoagulants Market Analysis and Forecast, by Region

10.1. Key Findings

10.2. Market Value Forecast, by Region

10.2.1. North America

10.2.2. Europe

10.2.3. Asia Pacific

10.2.4. Latin America

10.2.5. Middle East & Africa

10.3. Market Attractiveness, by Region

11. North America Anticoagulants Market Analysis and Forecast

11.1. Introduction

11.2. Market Value Forecast, by Route of Administration, 2016-2026

11.3. Market Value Forecast, by Drug Class, 2016-2026

11.4. Market Value Forecast, by Distribution Channel, 2016-2026

11.5. Market Value Forecast, by Distribution Channel, 2016-2026

11.6. Market Value Forecast, by Country, 2016-2026

11.7. Market Attractiveness Analysis

12. Europe Anticoagulants Market Analysis and Forecast

13. Asia Pacific Anticoagulants Market Analysis and Forecast

14. Latin America Anticoagulants Market Analysis and Forecast

15. Middle East & Africa Anticoagulants Market Analysis and Forecast

16. Competition Landscape

16.1. Market Player - Competition Matrix

16.2. Market Share Analysis, by Company (2017)

16.3. Company Profiles

16.4 Bayer AG

16.5. Boehringer Ingelheim International GmbH

16.6. Bristol-Myers Squibb Company

16.7. Daiichi Sankyo Company, Limited

16.8. Sanofi

16.9. Johnson & Johnson Services

For more information about this report visit https://www.researchandmarkets.com/r/49st2c

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900